Blood-based testing of mutations in patients with head and neck squamous cell carcinoma (HNSCC) using highly sensitive SafeSEQ technologyFlorentia Fostira, Amanda Psyrri, Kristin Stieler et al.|Annals of Oncology|2019Cited by 4
Predictive biomarkers for response to nivolumab in head and neck squamous cell carcinoma (HNSCC) (NCT#03652142).Amanda Psyrri, Periklis Foukas, Niki Gavrielatou et al.|Journal of Clinical Oncology|2019Cited by 2